(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PSAT1 mRNA] CTD PMID:31150632 1,2-dimethylhydrazine increases expression ISO RGD:1550459 6480464 1, 2-Dimethylhydrazine results in increased expression of PSAT1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1550459 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of PSAT1 mRNA] CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of PSAT1 mRNA CTD PMID:30723492 1-nitropyrene increases expression ISO RGD:1607031 6480464 1-nitropyrene results in increased expression of PSAT1 mRNA CTD PMID:19041380 17alpha-ethynylestradiol affects expression ISO RGD:1550459 6480464 Ethinyl Estradiol affects the expression of PSAT1 mRNA CTD PMID:17555576 17beta-estradiol multiple interactions ISO RGD:1607031 6480464 [Estradiol co-treated with Progesterone] results in increased expression of PSAT1 mRNA more ... CTD PMID:20660070 more ... 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of PSAT1 mRNA, [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of PSAT1 mRNA CTD PMID:26496021 , PMID:32741896 17beta-estradiol increases expression ISO RGD:1607031 6480464 Estradiol results in increased expression of PSAT1 mRNA CTD PMID:15757668 more ... 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of PSAT1 mRNA CTD PMID:32741896 1H-pyrazole increases expression ISO RGD:1550459 6480464 pyrazole results in increased expression of PSAT1 mRNA CTD PMID:17945193 2,2',4,4',5,5'-hexachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:20959002 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1607031 6480464 2 more ... CTD PMID:19095052 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1550459 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PSAT1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PSAT1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1550459 6480464 Tetrachlorodibenzodioxin results in increased expression of PSAT1 mRNA CTD PMID:25975270 , PMID:26290441 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550459 6480464 Tetrachlorodibenzodioxin affects the expression of PSAT1 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PSAT1 mRNA CTD PMID:20959002 , PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1607031 6480464 Tetrachlorodibenzodioxin results in decreased expression of PSAT1 mRNA CTD PMID:20106945 , PMID:21632981 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1607031 6480464 2 more ... CTD PMID:26705709 2-hydroxypropanoic acid increases expression ISO RGD:1607031 6480464 Lactic Acid results in increased expression of PSAT1 mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:20959002 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of PSAT1 mRNA CTD PMID:28522335 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1550459 6480464 [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in decreased expression of PSAT1 mRNA CTD PMID:29288687 4,4'-sulfonyldiphenol increases methylation ISO RGD:1607031 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of PSAT1 gene CTD PMID:31601247 4,4'-sulfonyldiphenol increases expression ISO RGD:1607031 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PSAT1 protein CTD PMID:34186270 8-Br-cAMP increases expression ISO RGD:1607031 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PSAT1 mRNA CTD PMID:22079614 acetamide increases expression EXP 6480464 acetamide results in increased expression of PSAT1 mRNA CTD PMID:31881176 acetylsalicylic acid decreases expression EXP 6480464 Aspirin results in decreased expression of PSAT1 mRNA CTD PMID:12800193 acrylamide increases expression ISO RGD:1607031 6480464 Acrylamide results in increased expression of PSAT1 mRNA CTD PMID:32763439 adefovir pivoxil decreases expression ISO RGD:1607031 6480464 adefovir dipivoxil results in decreased expression of PSAT1 mRNA CTD PMID:25596134 aflatoxin B1 affects expression ISO RGD:1607031 6480464 Aflatoxin B1 affects the expression of PSAT1 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of PSAT1 mRNA CTD PMID:23630614 , PMID:25378103 aflatoxin B1 decreases expression ISO RGD:1550459 6480464 Aflatoxin B1 results in decreased expression of PSAT1 mRNA CTD PMID:19770486 aldrin increases expression ISO RGD:1550459 6480464 Aldrin results in increased expression of PSAT1 mRNA CTD PMID:18579281 all-trans-retinoic acid decreases expression ISO RGD:1607031 6480464 Tretinoin results in decreased expression of PSAT1 mRNA CTD PMID:16249480 more ... alpha-hexachlorocyclohexane increases expression EXP 6480464 alpha-hexachlorocyclohexane results in increased expression of PSAT1 mRNA CTD PMID:17785943 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PSAT1 mRNA CTD PMID:16483693 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of PSAT1 mRNA CTD PMID:30779732 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1550459 6480464 pyrazolanthrone inhibits the reaction [Ozone results in increased expression of PSAT1 mRNA] CTD PMID:17460151 antimycin A increases expression ISO RGD:1607031 6480464 Antimycin A results in increased expression of PSAT1 mRNA CTD PMID:33512557 arachidonic acid increases expression ISO RGD:1607031 6480464 Arachidonic Acid results in increased expression of PSAT1 mRNA CTD PMID:16704987 aristolochic acid A increases expression ISO RGD:1607031 6480464 aristolochic acid I results in increased expression of PSAT1 protein CTD PMID:33212167 aristolochic acid A decreases expression ISO RGD:1607031 6480464 aristolochic acid I results in decreased expression of PSAT1 mRNA CTD PMID:33212167 arsenous acid decreases expression ISO RGD:1607031 6480464 Arsenic Trioxide results in decreased expression of PSAT1 mRNA CTD PMID:19128835 avobenzone decreases expression ISO RGD:1607031 6480464 avobenzone results in decreased expression of PSAT1 mRNA CTD PMID:31016361 azoxystrobin increases expression ISO RGD:1607031 6480464 azoxystrobin results in increased expression of PSAT1 mRNA CTD PMID:33512557 benzo[a]pyrene increases expression ISO RGD:1607031 6480464 Benzo(a)pyrene results in increased expression of PSAT1 mRNA CTD PMID:20106945 benzo[a]pyrene decreases expression ISO RGD:1607031 6480464 Benzo(a)pyrene results in decreased expression of PSAT1 protein CTD PMID:32717239 benzo[a]pyrene decreases expression ISO RGD:1550459 6480464 Benzo(a)pyrene results in decreased expression of PSAT1 mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO RGD:1550459 6480464 Benzo(a)pyrene results in increased expression of PSAT1 mRNA CTD PMID:20713471 , PMID:32417428 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1607031 6480464 7 more ... CTD PMID:20018196 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PSAT1 mRNA CTD PMID:18164116 beta-naphthoflavone increases expression ISO RGD:1607031 6480464 beta-Naphthoflavone results in increased expression of PSAT1 mRNA CTD PMID:32858204 bisphenol A decreases expression ISO RGD:1607031 6480464 bisphenol A results in decreased expression of PSAT1 mRNA CTD PMID:20678512 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PSAT1 mRNA CTD PMID:30816183 , PMID:32528016 bisphenol A affects expression ISO RGD:1607031 6480464 bisphenol A affects the expression of PSAT1 mRNA, bisphenol A affects the expression of PSAT1 protein CTD PMID:30903817 , PMID:34186270 bisphenol A increases expression ISO RGD:1607031 6480464 bisphenol A analog results in increased expression of PSAT1 mRNA, bisphenol A results in increased expression of PSAT1 mRNA CTD PMID:29275510 , PMID:32387340 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PSAT1 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of PSAT1 mRNA CTD PMID:26496021 Bisphenol B increases expression ISO RGD:1607031 6480464 bisphenol B results in increased expression of PSAT1 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1607031 6480464 bisphenol F results in increased expression of PSAT1 protein CTD PMID:34186270 butan-1-ol multiple interactions ISO RGD:1607031 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PSAT1 mRNA CTD PMID:29432896 butyric acid decreases expression EXP 6480464 Butyric Acid results in decreased expression of PSAT1 mRNA CTD PMID:12800193 cadmium atom multiple interactions ISO RGD:1607031 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PSAT1 protein CTD PMID:33040242 cadmium dichloride multiple interactions ISO RGD:1607031 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PSAT1 protein CTD PMID:33040242 cadmium dichloride increases expression ISO RGD:1607031 6480464 Cadmium Chloride results in increased expression of PSAT1 mRNA CTD PMID:26472689 cadmium dichloride affects expression ISO RGD:1607031 6480464 Cadmium Chloride affects the expression of PSAT1 mRNA CTD PMID:25596134 calcidiol decreases expression EXP 6480464 Calcifediol deficiency results in decreased expression of PSAT1 mRNA CTD PMID:17293106 cannabidiol multiple interactions ISO RGD:1607031 6480464 [Dronabinol co-treated with Cannabidiol] results in increased expression of PSAT1 mRNA CTD PMID:26504004 cannabidiol increases expression ISO RGD:1607031 6480464 Cannabidiol results in increased expression of PSAT1 mRNA CTD PMID:26504004 carbamazepine affects expression ISO RGD:1607031 6480464 Carbamazepine affects the expression of PSAT1 mRNA CTD PMID:24752500 , PMID:25979313 carbon nanotube increases expression ISO RGD:1550459 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 chloroacetaldehyde decreases expression ISO RGD:1607031 6480464 chloroacetaldehyde results in decreased expression of PSAT1 mRNA CTD PMID:25596134 chloroethene increases expression ISO RGD:1550459 6480464 Vinyl Chloride results in increased expression of PSAT1 mRNA CTD PMID:18579281 chloropicrin decreases expression ISO RGD:1607031 6480464 chloropicrin results in decreased expression of PSAT1 mRNA CTD PMID:26352163 cholesterol increases expression ISO RGD:1607031 6480464 Cholesterol results in increased expression of PSAT1 mRNA CTD PMID:26296894 choline multiple interactions ISO RGD:1550459 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PSAT1 mRNA CTD PMID:20938992 chromium(6+) affects expression ISO RGD:1550459 6480464 chromium hexavalent ion affects the expression of PSAT1 mRNA CTD PMID:28472532 cidofovir anhydrous increases expression ISO RGD:1607031 6480464 Cidofovir results in increased expression of PSAT1 mRNA CTD PMID:25596134 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of PSAT1 mRNA CTD PMID:22023808 cisplatin multiple interactions ISO RGD:1607031 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of PSAT1 mRNA CTD PMID:27392435 cisplatin increases expression ISO RGD:1607031 6480464 Cisplatin results in increased expression of PSAT1 mRNA CTD PMID:25596134 more ... clodronic acid increases expression ISO RGD:1607031 6480464 Clodronic Acid results in increased expression of PSAT1 mRNA CTD PMID:25596134 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PSAT1 mRNA CTD PMID:17602206 cobalt atom multiple interactions ISO RGD:1607031 6480464 [tungsten carbide co-treated with Cobalt] results in decreased expression of PSAT1 mRNA, [tungsten carbide co-treated with Cobalt] results in increased expression of PSAT1 mRNA CTD PMID:18078969 , PMID:23052192 cobalt dichloride decreases expression ISO RGD:1607031 6480464 cobaltous chloride results in decreased expression of PSAT1 mRNA CTD PMID:19376846 copper atom multiple interactions ISO RGD:1607031 6480464 [Chelating Agents binds to Copper] which results in increased expression of PSAT1 mRNA, [Disulfiram binds to Copper] which results in increased expression of PSAT1 mRNA CTD PMID:24690739 , PMID:30911355 copper atom increases expression EXP 6480464 Copper results in increased expression of PSAT1 mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:1607031 6480464 [Chelating Agents binds to Copper] which results in increased expression of PSAT1 mRNA, [Disulfiram binds to Copper] which results in increased expression of PSAT1 mRNA CTD PMID:24690739 , PMID:30911355 copper(0) increases expression EXP 6480464 Copper results in increased expression of PSAT1 mRNA CTD PMID:30556269 copper(II) sulfate increases expression ISO RGD:1607031 6480464 Copper Sulfate results in increased expression of PSAT1 mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:1607031 6480464 Cyclosporine results in decreased expression of PSAT1 mRNA CTD PMID:25562108 cyclosporin A increases expression ISO RGD:1607031 6480464 Cyclosporine results in increased expression of PSAT1 mRNA CTD PMID:20106945 more ... deguelin increases expression ISO RGD:1607031 6480464 deguelin results in increased expression of PSAT1 mRNA CTD PMID:33512557 deoxynivalenol decreases expression ISO RGD:1607031 6480464 deoxynivalenol results in decreased expression of PSAT1 mRNA CTD PMID:31863870 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of PSAT1 mRNA CTD PMID:20032058 dexamethasone multiple interactions ISO RGD:1550459 6480464 [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in decreased expression of PSAT1 mRNA CTD PMID:29288687 dexamethasone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of PSAT1 mRNA] CTD PMID:20032058 diarsenic trioxide decreases expression ISO RGD:1607031 6480464 Arsenic Trioxide results in decreased expression of PSAT1 mRNA CTD PMID:19128835 dibutyl phthalate decreases expression ISO RGD:1550459 6480464 Dibutyl Phthalate results in decreased expression of PSAT1 mRNA CTD PMID:21266533 dichloroacetic acid increases expression ISO RGD:1550459 6480464 Dichloroacetic Acid results in increased expression of PSAT1 mRNA CTD PMID:28962523 diclofenac affects expression ISO RGD:1607031 6480464 Diclofenac affects the expression of PSAT1 mRNA CTD PMID:24752500 Didecyldimethylammonium increases expression ISO RGD:1607031 6480464 didecyldimethylammonium results in increased expression of PSAT1 mRNA CTD PMID:32763356 dioxygen decreases expression ISO RGD:1607031 6480464 Oxygen deficiency results in decreased expression of PSAT1 mRNA CTD PMID:25596134 , PMID:26516004 disodium selenite increases expression ISO RGD:1607031 6480464 Sodium Selenite results in increased expression of PSAT1 mRNA CTD PMID:24383545 disulfiram multiple interactions ISO RGD:1607031 6480464 [Disulfiram binds to Copper] which results in increased expression of PSAT1 mRNA CTD PMID:24690739 dorsomorphin multiple interactions ISO RGD:1607031 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PSAT1 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1607031 6480464 Doxorubicin results in decreased expression of PSAT1 mRNA CTD PMID:29803840 ethanol increases expression ISO RGD:1550459 6480464 Ethanol results in increased expression of PSAT1 mRNA CTD PMID:19167417 ethanol multiple interactions ISO RGD:1550459 6480464 Ethanol affects the expression of and affects the splicing of PSAT1 mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:1607031 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PSAT1 mRNA CTD PMID:29432896 fenpyroximate increases expression ISO RGD:1607031 6480464 fenpyroximate results in increased expression of PSAT1 mRNA CTD PMID:33512557 flutamide increases expression EXP 6480464 Flutamide results in increased expression of PSAT1 mRNA CTD PMID:24136188 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of PSAT1 mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:1550459 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PSAT1 mRNA more ... CTD PMID:20938992 , PMID:22206623 furan increases expression EXP 6480464 furan results in increased expression of PSAT1 mRNA CTD PMID:25539665 , PMID:26194646 gemcitabine increases expression ISO RGD:1607031 6480464 Gemcitabine results in increased expression of PSAT1 mRNA CTD PMID:17039268 genistein increases expression ISO RGD:1607031 6480464 Genistein results in increased expression of PSAT1 mRNA CTD PMID:15757668 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of PSAT1 mRNA CTD PMID:33387578 gold atom decreases expression ISO RGD:1550459 6480464 Gold analog results in decreased expression of PSAT1 protein CTD PMID:24780912 gold(0) decreases expression ISO RGD:1550459 6480464 Gold analog results in decreased expression of PSAT1 protein CTD PMID:24780912 hydrazine increases expression ISO RGD:1550459 6480464 hydrazine results in increased expression of PSAT1 mRNA CTD PMID:15282401 hydrogen peroxide decreases expression ISO RGD:1607031 6480464 Hydrogen Peroxide results in decreased expression of PSAT1 mRNA CTD PMID:34581912 ifosfamide increases expression ISO RGD:1607031 6480464 Ifosfamide results in increased expression of PSAT1 mRNA CTD PMID:25596134 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of PSAT1 mRNA CTD PMID:21396975 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PSAT1 mRNA more ... CTD PMID:22129741 irinotecan increases response to substance ISO RGD:1607031 6480464 PSAT1 protein results in increased susceptibility to Irinotecan CTD PMID:16734730 ivermectin decreases expression ISO RGD:1607031 6480464 Ivermectin results in decreased expression of PSAT1 protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:1550459 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PSAT1 mRNA CTD PMID:20938992 lamivudine multiple interactions ISO RGD:1607031 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of PSAT1 mRNA CTD PMID:15784690 Licarin A multiple interactions ISO RGD:1550459 6480464 [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in decreased expression of PSAT1 mRNA CTD PMID:29288687 lucanthone decreases expression ISO RGD:1607031 6480464 Lucanthone results in decreased expression of PSAT1 mRNA CTD PMID:21148553 menadione affects expression ISO RGD:1607031 6480464 Vitamin K 3 affects the expression of PSAT1 mRNA CTD PMID:20044591 metformin increases expression EXP 6480464 Metformin results in increased expression of PSAT1 mRNA CTD PMID:31324951 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of PSAT1 mRNA CTD PMID:28341135 methylmercury chloride increases expression ISO RGD:1607031 6480464 methylmercuric chloride results in increased expression of PSAT1 mRNA CTD PMID:28001369 monosodium L-glutamate increases expression ISO RGD:1550459 6480464 Sodium Glutamate results in increased expression of PSAT1 mRNA CTD PMID:22078008 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of PSAT1 mRNA CTD PMID:21515302 N-acetyl-L-cysteine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PSAT1 mRNA, Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PSAT1 mRNA] CTD PMID:22129741 N-methyl-4-phenylpyridinium increases expression ISO RGD:1607031 6480464 1-Methyl-4-phenylpyridinium results in increased expression of PSAT1 mRNA CTD PMID:24810058 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of PSAT1 mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PSAT1 mRNA more ... CTD PMID:17602206 more ... N-nitrosodiethylamine increases expression ISO RGD:1550459 6480464 Diethylnitrosamine results in increased expression of PSAT1 mRNA CTD PMID:24535843 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of PSAT1 mRNA CTD PMID:19638242 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of PSAT1 mRNA CTD PMID:24136188 neomycin multiple interactions ISO RGD:1550459 6480464 Plant Oils inhibits the reaction [Neomycin results in decreased expression of PSAT1 mRNA] CTD PMID:30626089 neomycin decreases expression ISO RGD:1550459 6480464 Neomycin results in decreased expression of PSAT1 mRNA CTD PMID:30626089 nickel dichloride increases expression ISO RGD:1607031 6480464 nickel chloride results in increased expression of PSAT1 mRNA CTD PMID:17312168 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of PSAT1 mRNA CTD PMID:33484710 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PSAT1 mRNA CTD PMID:25729387 ozone increases expression ISO RGD:1550459 6480464 Ozone results in increased expression of PSAT1 mRNA CTD PMID:17095637 ozone multiple interactions ISO RGD:1550459 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PSAT1 mRNA more ... CTD PMID:17460151 , PMID:34911549 paracetamol affects expression ISO RGD:1550459 6480464 Acetaminophen affects the expression of PSAT1 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of PSAT1 mRNA CTD PMID:30723492 paracetamol increases expression ISO RGD:1607031 6480464 Acetaminophen results in increased expression of PSAT1 mRNA CTD PMID:21420995 , PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PSAT1 mRNA CTD PMID:18246545 paraquat increases expression ISO RGD:1607031 6480464 Paraquat results in increased expression of PSAT1 mRNA CTD PMID:34097952 perfluorononanoic acid increases expression ISO RGD:1607031 6480464 perfluoro-n-nonanoic acid results in increased expression of PSAT1 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1607031 6480464 perfluorooctane sulfonic acid results in increased expression of PSAT1 mRNA, perfluorooctane sulfonic acid results in increased expression of PSAT1 protein CTD PMID:24301089 , PMID:32588087 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of PSAT1 mRNA CTD PMID:19162173 perfluorooctanoic acid increases expression ISO RGD:1607031 6480464 perfluorooctanoic acid results in increased expression of PSAT1 mRNA CTD PMID:32588087 PhIP decreases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in decreased expression of PSAT1 mRNA CTD PMID:29877212 phorone affects expression EXP 6480464 phorone affects the expression of PSAT1 mRNA CTD PMID:18198479 picoxystrobin increases expression ISO RGD:1607031 6480464 picoxystrobin results in increased expression of PSAT1 mRNA CTD PMID:33512557 pirinixic acid multiple interactions ISO RGD:1607031 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PSAT1 mRNA CTD PMID:19710929 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of PSAT1 mRNA CTD PMID:17164430 , PMID:19162173 pirinixic acid increases expression ISO RGD:1550459 6480464 pirinixic acid results in increased expression of PSAT1 mRNA CTD PMID:18301758 piroxicam decreases expression ISO RGD:1607031 6480464 Piroxicam results in decreased expression of PSAT1 mRNA CTD PMID:21858171 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of PSAT1 mRNA CTD PMID:19162173 progesterone increases expression ISO RGD:1607031 6480464 Progesterone results in increased expression of PSAT1 mRNA CTD PMID:18037150 progesterone multiple interactions ISO RGD:1607031 6480464 [Estradiol co-treated with Progesterone] results in increased expression of PSAT1 mRNA CTD PMID:20660070 propiconazole increases expression ISO RGD:1550459 6480464 propiconazole results in increased expression of PSAT1 mRNA CTD PMID:21278054 prostaglandin A1 increases metabolic processing ISO RGD:1550459 6480464 prostaglandin A1 analog results in increased metabolism of PSAT1 protein CTD PMID:19800325 prothioconazole increases expression ISO RGD:1607031 6480464 prothioconazole results in increased expression of PSAT1 mRNA CTD PMID:35048155 pyrimidifen increases expression ISO RGD:1607031 6480464 pyrimidifen results in increased expression of PSAT1 mRNA CTD PMID:33512557 quercetin decreases expression ISO RGD:1607031 6480464 Quercetin results in decreased expression of PSAT1 mRNA CTD PMID:21632981 rac-lactic acid increases expression ISO RGD:1607031 6480464 Lactic Acid results in increased expression of PSAT1 mRNA CTD PMID:30851411 rotenone increases expression EXP 6480464 Rotenone results in increased expression of PSAT1 mRNA CTD PMID:28374803 rotenone increases expression ISO RGD:1607031 6480464 Rotenone results in increased expression of PSAT1 mRNA CTD PMID:33512557 rotenone decreases expression ISO RGD:1607031 6480464 Rotenone results in decreased expression of PSAT1 mRNA CTD PMID:29955902 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:1607031 6480464 S-(1, 2-dichlorovinyl)cysteine results in increased expression of PSAT1 mRNA CTD PMID:33725128 SB 431542 multiple interactions ISO RGD:1607031 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PSAT1 mRNA CTD PMID:27188386 silicon dioxide affects secretion ISO RGD:1607031 6480464 Silicon Dioxide analog affects the secretion of PSAT1 protein CTD PMID:25895662 silicon dioxide decreases expression ISO RGD:1607031 6480464 Silicon Dioxide analog results in decreased expression of PSAT1 mRNA, Silicon Dioxide results in decreased expression of PSAT1 mRNA CTD PMID:23806026 , PMID:25351596 sodium arsenite increases expression ISO RGD:1607031 6480464 sodium arsenite results in increased expression of PSAT1 mRNA CTD PMID:25879800 sodium arsenite affects expression ISO RGD:1607031 6480464 sodium arsenite affects the expression of PSAT1 mRNA CTD PMID:34032870 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of PSAT1 mRNA CTD PMID:25993096 sulforaphane increases expression ISO RGD:1607031 6480464 sulforaphane results in increased expression of PSAT1 mRNA CTD PMID:31838189 sunitinib increases expression ISO RGD:1607031 6480464 Sunitinib results in increased expression of PSAT1 mRNA CTD PMID:31533062 T-2 toxin decreases expression ISO RGD:1607031 6480464 T-2 Toxin results in decreased expression of PSAT1 mRNA CTD PMID:31863870 , PMID:34581912 tebufenpyrad increases expression ISO RGD:1607031 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of PSAT1 mRNA CTD PMID:33512557 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of PSAT1 mRNA CTD PMID:21515302 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of PSAT1 mRNA, Testosterone inhibits the reaction [Dexamethasone results in decreased expression of PSAT1 mRNA] CTD PMID:20032058 , PMID:32741896 tetrachloroethene increases expression ISO RGD:1550459 6480464 Tetrachloroethylene results in increased expression of PSAT1 mRNA CTD PMID:28973375 tetrachloromethane increases expression ISO RGD:1550459 6480464 Carbon Tetrachloride results in increased expression of PSAT1 mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of PSAT1 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PSAT1 mRNA] CTD PMID:31150632 thifluzamide increases expression ISO RGD:1607031 6480464 thifluzamide results in increased expression of PSAT1 mRNA CTD PMID:33512557 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PSAT1 mRNA CTD PMID:25729387 triacsin C increases expression ISO RGD:1607031 6480464 triacsin C results in increased expression of PSAT1 mRNA CTD PMID:16704987 Tributyltin oxide increases expression ISO RGD:1550459 6480464 bis(tri-n-butyltin)oxide results in increased expression of PSAT1 mRNA CTD PMID:25270620 trichloroethene increases expression ISO RGD:1550459 6480464 Trichloroethylene results in increased expression of PSAT1 mRNA CTD PMID:25549359 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of PSAT1 mRNA CTD PMID:33387578 trimellitic anhydride increases expression ISO RGD:1550459 6480464 trimellitic anhydride results in increased expression of PSAT1 mRNA CTD PMID:19042947 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of PSAT1 mRNA CTD PMID:30589522 trovafloxacin decreases expression ISO RGD:1550459 6480464 trovafloxacin results in decreased expression of PSAT1 mRNA CTD PMID:35537566 tungsten increases expression ISO RGD:1550459 6480464 Tungsten results in increased expression of PSAT1 mRNA CTD PMID:30912803 Tungsten carbide multiple interactions ISO RGD:1607031 6480464 [tungsten carbide co-treated with Cobalt] results in decreased expression of PSAT1 mRNA, [tungsten carbide co-treated with Cobalt] results in increased expression of PSAT1 mRNA CTD PMID:18078969 , PMID:23052192 tunicamycin increases expression ISO RGD:1607031 6480464 Tunicamycin results in increased expression of PSAT1 mRNA, Tunicamycin results in increased expression of PSAT1 protein CTD PMID:29453283 , PMID:33545341 valproic acid increases expression ISO RGD:1607031 6480464 Valproic Acid results in increased expression of PSAT1 mRNA CTD PMID:23179753 more ... valproic acid increases methylation ISO RGD:1607031 6480464 Valproic Acid results in increased methylation of PSAT1 gene CTD PMID:29501571 valproic acid decreases expression ISO RGD:1607031 6480464 Valproic Acid results in decreased expression of PSAT1 protein CTD PMID:29501571 vorinostat multiple interactions ISO RGD:1607031 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PSAT1 mRNA CTD PMID:27188386 zidovudine multiple interactions ISO RGD:1607031 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of PSAT1 mRNA CTD PMID:15784690 zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of PSAT1 mRNA CTD PMID:16140947 zinc atom multiple interactions EXP 6480464 Zinc inhibits the reaction [Zinc deficiency results in increased expression of PSAT1 mRNA] CTD PMID:16140947 zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of PSAT1 mRNA CTD PMID:16140947 zinc(0) multiple interactions EXP 6480464 Zinc inhibits the reaction [Zinc deficiency results in increased expression of PSAT1 mRNA] CTD PMID:16140947 zoledronic acid decreases expression ISO RGD:1607031 6480464 zoledronic acid results in decreased expression of PSAT1 mRNA CTD PMID:24714768 , PMID:25596134